Ayobami Olajuyin

Dr Ayobami Matthew Olajuyin received his PhD in Biochemical Engineering (Molecular Biology and Metabolic Engineering) from the University of Chinese Academy of Sciences Beijing China in 2018, where he investigated the efficient production of succinic acid and other biochemicals utilizing waste biomass by recombinant E. coli.

Dr. Olajuyin did his postdoctoral work (2018-2020) in the laboratory of Prof Xiaoju Zhang at Henan Provincial People’s Hospital, The People’s Hospital of Zhengzhou University Zhengzhou China, investigating CD146 T cells in lung cancer: its function, detection and clinical implications as a biomarker and therapeutic target. He also investigated AT2 cells as progenitor cells for lung injury repairs with his collaborator Prof Honglong Ji at Texas University Health Center, Tyler Texas USA. He did his Visiting Research on Pathophysiology (Pulmonary hypertension) at Tongji Medical College of Huazhong University of Science and Technology Hankou China with Prof Qinghua Hu.

Dr. Olajuyin has published several papers in international peer reviewed, high impact factor journals including Bioresource Technology, Journal of Thoracic Oncology, Environmental Science and Pollution Research, Food and Chemical Toxicology, Cell Death Discovery, Cancer Cell international, Anti-Cancer Research, Waste Biomass and Volarization, Bioprocess and Biosystems Engineering, Environmental Progress & Sustainable Energy, Biotechnology Report and Review Editor of Pharmacology of Ion Channels and Channelopathies. He is a scholar who has attended several international conferences and won so many awards.

His current research interest includes toxicology, genomics, oncology and biotechnology. He is also zealous about synthetic biology, metabolic engineering, and genome editing) on the environment and human health. Skilled in UV/Vis Spectroscopy, PCR, ELISA, Gene Editing, Bioengineering, Biotechnology, Flow cytometry, Immunofluorescence, Immunohistochemistry, Research and Development (R&D), Biochemistry, Analytical Chemistry, Cancer Research, Stem Cell Research, T cell Research, and Animal Research.